Table 2.

Baseline characteristics for patients with versus without PVD undergoing TAVR

	Unmatched		Matched
	TAVR-PVD (n = 42,531)	TAVR- non-PVD (n = 276,825)	TAVR-PVD (n = 42,531)	TAVR- non-PVD (n = 41,982)	Standardized mean difference
Age, years (mean + SD)	79.3 + 8.0	79.1 + 8.6	79.3 + 8.0	79.3 + 8.0	0.00
Female	34.9%	45.8%	34.9%	41.9%	0.15
Diabetes mellitus	39.3%	37.7%	39.3%	38.7%	– 0.02
Chronic kidney disease stage 3 or more	43.9%	34.0%	43.9%	38.1%	– 0.12
End-stage renal disease	4.6%	3.6%	4.6%	3.9%	– 0.04
Obesity BMI>40	3.7%	6.8%	3.7%	6.0%	0.11
Chronic pulmonary disease	33.6%	26.3%	33.6%	30.1%	– 0.07
Number of vascular bed diseases	0-vessel (61.2%)/ 1-vessel (38.8%)	2-vessel (86.5%)/ 3-vessel (13.5%)	0-vessel (60.2%)/ 1-vessel (39.8%)	2-vessel (86.5%)/ 3-vessel (13.5%)	– 4.1